Retatrutide is a promising compound currently being studied primarily for weight management and metabolic health. Through its unique mechanism of action targeting three hormone receptors — GLP-1, GIP, and glucagon — retatrutide has demonstrated significant weight loss in clinical studies. In addition, researchers are investigating its potential positive effects on various metabolic markers. Retatrutide could therefore become an interesting future treatment option for obesity and related metabolic conditions.
Store in a refrigerator at 2-8°C until November 2027. Once dissolved, it can be used for 10 days under refrigeration. For research purposes only. Not for human use.
